XS-001

N/A

Report date: 2025/06/13 11:09:46

Base Information

Drug NameXS-001
Drug Alias Name人多能干细胞来源多巴胺能神经前体细胞XS_001XS-001hiPSC-DAP
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesXellSmart Bio-Pharmaceutical (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Dongfang Hospital (Affiliated Dongfang Hospital Of Tongji University)Shanghai Oriental HospitalXellSmart Bio-Pharmaceutical (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A